Transcriptome analysis of all lymphoid clusters indicated CD8 T cells as the main lymphocyte subset infiltrating the tumor upon combination therapy, with concomitant reduction of NK, CD4, and Treg clusters relative to PBS-treated tumors (Fig. 3c). This evidence concerns the gene CD4 and neoplasm.